POSTTRANSLATIONAL MODIFICATIONS OF BRAIN AND ERYTHROCYTE BAND-3 DURING AGING AND DISEASE

Citation
Mmb. Kay et al., POSTTRANSLATIONAL MODIFICATIONS OF BRAIN AND ERYTHROCYTE BAND-3 DURING AGING AND DISEASE, Cellular and molecular biology, 42(7), 1996, pp. 919-944
Citations number
78
Categorie Soggetti
Cell Biology",Biology
ISSN journal
01455680
Volume
42
Issue
7
Year of publication
1996
Pages
919 - 944
Database
ISI
SICI code
0145-5680(1996)42:7<919:PMOBAE>2.0.ZU;2-Y
Abstract
Band 3 performs the same structural and functional activities in adult brain as it does in erythrocytes. It ages as cells and tissues age Ou r studies, to date, indicate that the anion transport ability of band 3 decreases in brains and lymphocytes from old mice. This decreased tr ansport ability precedes obvious structural changes, such as band 3 de gradation and generation of SCA and is the earliest change thus far de tected in band 3. The following changes occur in lymphocytes, erythroc ytes and brain band 3 with aging: 1) a decreased efficiency of anion t ransport (decreased V-max) in spite of an increase in number of anion binding sites (increased K-m, 2) a decreased glucose transport, 3) P-3 2 labeling in vitro, 4) an increased degradation to smaller fragments as detected by quantitative binding of antibodies to band 3 breakdown products and residue 812-830, and 5) a binding of physiologic IgG auto antibodies in situ. The latter three findings indicate that posttransl ational changes occur. In addition, the anion transporter, band 3, und ergoes an as yet undefined change that results in binding of ''980'' a ntibodies to aged band 3. Posttranslational changes in AD include decr eased brain and RBC phosphorylation of a M(r) approximate to 135, 113 and 45 kDa band 3 polypeptides due to the phosphorylation site being a lready occupied, increased degradation of band 3, alterations in band 3 recognized by antibodies, and decreased anion and glucose transport by blood cells. Band 3 in erythrocytes of AD patients has a different immunological identity from normal band 3 as evidenced by the binding of antibodies described in this study. AD may be preferentially manife sted in the brain because neurons accumulate damage throughout the lif etime as they do not regenerate or undergo cell division. We suspect, and our data indicate, that the same mechanism(s) of AD occurs in all cells, but that the manifestations differ due to different cell protei ns and functions.